by Dr. Mathias Schmidt (ANME+EUAA)
From 30 September to 2 October the symposium “TradeReg 2013: Regulation of Herbal and Traditional Medicinal Products – European and global strategies” took place in Bonn (Germany). During this three-day-symposium the regulatory approaches were presented for Europe and beyond the EU borders: there were, for example, presentations on the regulatory situation of herbal medicinal products in Brazil, Japan, Canada or the United States of America.
Of course, a major emphasis went to the collected experience with the registration of traditional herbal medicinal products in Europe.In view of the current European situation many participants had hoped for answers to pressing questions, especially with respect to the transfer of unregulated food supplements to the market segment of regulated traditional medicinal products. This hope was, however, deceived: ultimately the messages gave more information on what is not possible than aids to the question how manufacturers of food supplements could make practical use the so-called facilitated registration.
Washington, D.C., September - The U.S. Senate unanimously passed a resolution designating October 7 – October 13 as Naturopathic Medicine Week.
What about the concern of the association „shamanic network Europe e.V.“ under the umbrella of ANME e.V.?
We just finished our first festival at castle Ludwigstein, right in the middle of Germany. Not only Germans, but Norwegian, Estonian, Austrian, Finnish and Irish guests came to the 4 day event of „Shamanic Network Europe e.V.“ The topic there was „traditional healing work and spiritual customs in Europe“. Till now we arranged only week-end seminaries about the same subjects. For us, these both aspects are closely connected. We will show this by an important example.
Statement from Michael McIntyre chair of the European herbal and Traditional Medicine Practitioners Association (EHPA), 24/09/2013
The regulation of herbal medicine practitioners of all traditions, western, Chinese Ayurvedic and Tibetan, has been a matter of ongoing debate in the UK for the past 15 years. In 2000 the prestigious House of Lords’ Select Committee on Science and Technology recommended in its report on complementary and alternative medicine (CAM) that herbal practitioners should be statutorily regulated like doctors and nurses.
Following this in 2001 the UK Government launched a Department of Health Working Group to review this option. The Working Group, under independent chairmanship, published its findings in 2003 also calling for the statutory regulation of herbal practitioners.
By Nand de Herd, former President of ECHAMP (European Coaltion on Homeopatic and Anthroposophic Medicinal Products)
Recent surveys in France, Czech Republic, Spain, Italy, Germany and Belgium, among others, show a growing demand of citizens for CAM healthcare provision, not only in general practice, but also for specialists in hospitals and in pharmacies. This increasingly brings into question the offer from healthcare providers and products.
The European institutions have already taken an interest in topics such as health inequalities and cross border; they are now interested in knowing more about the availability of medicinal products for citizens and prescribers.
In 2007, the Heads of Medicines Agencies (HMA) identified a number of availability concerns which they published in a report Availability of Human Medicinal Products.
More recently, in 2011, the European Parliament published a study Differences in costs of and access to pharmaceutical products in the EU.